Page last updated: 2024-10-28

guanfacine and Stress Disorders, Traumatic

guanfacine has been researched along with Stress Disorders, Traumatic in 1 studies

Guanfacine: A centrally acting antihypertensive agent with specificity towards ADRENERGIC ALPHA-2 RECEPTORS.

Stress Disorders, Traumatic: Anxiety disorders manifested by the development of characteristic symptoms following a psychologically traumatic event that is outside the normal range of usual human experience. Symptoms include re-experiencing the traumatic event, increased arousal, and numbing of responsiveness to or reduced involvement with the external world. Traumatic stress disorders can be further classified by the time of onset and the duration of these symptoms.

Research Excerpts

ExcerptRelevanceReference
"In the presence of PTSD symptoms, children with ADHD experienced significantly improved ADHD symptom scores, suggesting that comorbidity does not attenuate an ADHD symptom response to GXR therapy."2.78An open-label study of guanfacine extended release for traumatic stress related symptoms in children and adolescents. ( Banga, A; Connor, DF; Grasso, DJ; Pearson, GS; Slivinsky, MD, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Connor, DF1
Grasso, DJ1
Slivinsky, MD1
Pearson, GS1
Banga, A1

Trials

1 trial available for guanfacine and Stress Disorders, Traumatic

ArticleYear
An open-label study of guanfacine extended release for traumatic stress related symptoms in children and adolescents.
    Journal of child and adolescent psychopharmacology, 2013, Volume: 23, Issue:4

    Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Attention Deficit Disorder with Hyperactivity; Chi

2013